ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements with these filters
Promoter Sachidanand Hariram Upadhyay proposed reinvesting proceeds from his prior sale of shares into the company's medical device unit expansion.
Lord’s Mark Industries has advanced its AI-powered breast cancer screening technology to final clinical trial stages. The company targets a global commercial launch by April 2027.
Promoter Director Mr. Sachidanand H Upadhyay sold 1.04 crore shares on BSE for ₹87.39 Crore. Stake reduced from 77.54% to 75.11%.
Lord's Mark promoter Sachidanand Upadhyay disposed 1.04 crore shares via open market, cutting his stake from 77.54% to 75.11%.
Lord's Mark Industries completed Phase I Silvassa expansion, adding 18 surgical/orthopaedic SKUs (36 to 54). Commercial operations commence October 11, 2026.
Lord's Mark Industries is a MedTech and Renewable Energy conglomerate focused on high-margin diagnostic innovations and a ₹3,000+ Cr solar order pipeline.
The board approved a proposal for an Offer for Sale (OFS) of up to 3% of equity capital by promoters to meet minimum public shareholding requirements.
Lords Mark Industries Ltd has issued a notice for its 46th Annual General Meeting, scheduled to be held on September 30, 2026.
Lord's Mark Industries Limited has filed its 46th Annual Report for the financial year 2025-26 and the notice of its upcoming 46th Annual General Meeting.
Lords Mark Industries entered a strategic partnership with ARKALL Holdings for Caribbean healthcare expansion. The collaboration targets $100 million in export revenue from diagnostic and medical device commercialisation.
Lords Mark Industries reported Q1 FY27 results, achieving 280 Cr topline and 32 Cr bottom line. The firm is transitioning from traditional energy to high-margin MedTech and diagnostics.
Infomerics upgraded Lord's Mark Industries Limited's credit rating to IVR A-/Stable for long-term and IVR A2+ for short-term bank facilities totaling Rs. 260.37 Crore.
Lord's Mark Industries Limited scheduled its 46th Annual General Meeting for September 30, 2026. The company set September 23, 2026, as the cut-off date for e-voting.
Lord’s Mark Industries announced a major strategic expansion including a demerger of its energy business, incorporation of UK and Swiss subsidiaries, and the establishment of 50 dialysis centres.
Lords Mark Industries Ltd reported revenue from operations of ₹307.7 Cr and net profit of ₹33.2 Cr for Q1 FY27.
Lord's Mark Industries Limited received a manufacturing license for its Biomescan Analytics Platform. This platform is India's first licensed In Vitro Diagnostic Software for microbiome assessments.
Lord's Mark Industries' board approved a restructuring scheme, including an OFS and Rights Issue, to comply with Minimum Public Shareholding requirements. They also appointed a secretarial auditor.
Lord's Mark Industries has scheduled a board meeting for August 6, 2026, to discuss Minimum Public Shareholding compliance and appoint a secretarial auditor.
Lord's Mark Industries Limited announced the resignation of M/s. BKP & Associates as Secretarial Auditor, effective August 1, 2026.
Lord's Mark Industries Limited announced the resignation of its Secretarial Auditor, M/s. BKP & Associates, effective August 01, 2026.
Lord's Mark Industries clarified that its 'Trading Restricted' status on BSE is a standard surveillance mechanism post-IBC, not an indication of any adverse operational or financial issues.
Lord's Mark Industries Limited has applied for listing and trading approval on the National Stock Exchange of India. The company's equity shares are currently listed on BSE Limited.
Lord's Mark Industries issued a corrigendum correcting the previously announced issue price of equity shares from ₹10 to ₹195 per share.
Lord's Mark Industries allotted 7,02,167 equity shares on a preferential basis per a High Court order. The shares, issued at ₹10 each, settle the specified legal agreement.
Lord's Mark Industries Ltd has scheduled a board meeting on August 13, 2026, to approve quarterly financial results and Annual General Meeting related matters.
Ms. Bhavini Rajkumar Chandnani has resigned as Company Secretary & Compliance Officer of Lord's Mark Industries Limited, effective from the close of business hours on August 20, 2026.
Lords Mark Industries won a contract from CREDA for Solar Home Lighting Systems. The order covers execution across the entire state of Chhattisgarh.
Lord's Mark Industries is seeking BSE listing approval for 10,28,483 equity shares issued to BCCL. The ₹16.25 Crore conversion at ₹158 per share follows a High Court settlement.
Lords Mark Industries Ltd reported net profit of ₹12.9 Cr for Q3 FY26.